Navigation Links
Tendril SDX Model 1688TC

ProductsTendril SDX Model 1688TC
Company St. Jude Medical, Inc.
Item Tendril SDX Model 1688TC
Features 
  • Steroid elution
  • TiN-coated electrodes
  • Silicone insulation
  • Fast-Pass coating
  • TC models use a standard clip-on tool
Description The Tendril SDX model 1688 and model 1488 active-fixation leads are among the world's thinnest extendable/retractable pacing leads, offering the unsurpassed handling advantages, performance, and reliability evident in St. Jude Medical's line of active-fixation leads. Implantable with a 7 F introducer, the reduced body diameter of the Tendril SDX lead is designed to lower the incidence of venous obstruction and allow introduction in smaller, more tortuous venous pathways.
Info St. Jude Medical, Inc.
Customer Service: (800) 328-9634
Web site: http://www.sjm.com

Related medicine products :

1. Tendril DX Model 1388 T/TC
2. Tendril DX
3. Tendril DX Model 1388 K
4. Tendril SDX Model 1488TC
5. Tendril SDX
6. Tendril SDX Model 1488K
7. Tendril SDX Model 1688T
8. Tendril SDX Model 1488T
9. Tendril™ ST Pacing Lead
10. Reliance Stool, Model 5346
11. Reliance Stools, Model 5340
PROXIMATE ILS Circular Sizer Set
VALTRAC™ Reusable Purstring Device
EEA™ Reusable 34 mm Sizer
Calcitonin Assay Immunoradiometric (IRMA) Assay
Medicine Products:
(Date:11/23/2009)...re/--JustintimefortheThanksgivingcelebration, tur...forcookingupadeliciousmeal:deep-friedturkeyin100%p... turkeyfrying.net alsoprovidesrecipesfromthele...takingtheturkeybeyondThanksgiving.Thenewlylaunched...ryingwith100%peanutoil. ,, "Ienjoyfryingwithpea...
(Date:11/23/2009)...s to treatment advances, study finds , ,...ontent of saliva changes as people age, and better... simple test to diagnose and treat age-related dis...ains numerous proteins that play a role in digesti...hers are trying to find ways to use these proteins...
(Date:11/23/2009)...Health System study has found that one out of five...ly 100 pounds or more overweight. , Researchers ...e 2 diabetes are obese, and 20.7 percent are morbi... 2 diabetes, 1 in 3 is morbidly obese. , "The ra... increasing at a very alarming rate, and this has ...
(Date:11/23/2009)...ave been a simple case for a New York auto acciden... charge. , New York (PRWE...e for New York auto accident attorneys passed to...rage turned fatal., , , , ,According to the New ...s shot and killed during a heated road-rage argume...
(Date:11/23/2009)...re/--ChristineHoehnehasjoined LocktonBenefitGroup ....HoehnewillserveasanAccountExecutiveinLockton,s In...neapolis office. ,, (Logo: http://www.newscom.c...ethrilledtohaveChristinejoinourteam,"saidPamEnrigh...hebroadensourabilitytoassistourmultinationalclient...
Breaking Medicine News(10 mins):Health News:Diabetics show alarming increase in morbid obesity 2Health News:An Incident of Road Rage Turns Into Murder 2Health News:Lockton Benefit Group Expands International Benefit Team 2
... that looks matter for everyone from presidential ...risis is forcing many consumers to re-evaluate the... and plastic surgeon polls are being release in co...tober 31st through November 5th. , "It appears mo...
...f Vertebral Compression Fracture Treatment Using...t, SAN JOSE, Calif., Oct. 28 DFine, Inc., a deve... vertebral compression fractures,(VCFs), has secur...ure Partners and Vanguard Ventures., DFine is ded...
...e Report Card Provides,Information on NY, NJ, RI, ...ty, Payments, LAKE SUCCESS, N.Y., Oct. 28 Health...U.S. have a unique tool for,evaluating the region,...ata on the cost and quality of care received by,me...
...f Universit Laval researchers has shown that the m...re exacerbated in the brains of mice fed a diet ri...the studywhich suggests that diets typical of most...e this, the team led by Frdric Calon used a type o...
...d 2008, HARRISBURG, Pa., Oct. 28 More than 600,P...al Conference of The,National Alliance on Mental I... "Today,s Family and the Faces of Mental Illness: ...open to the,public, will take place Wednesday, Oct...
...etween leading researchers in academia and industr...ds to discovery of method for promoting HEK 293 ce...rom colostrum. , Fort Col...ng the benefit of using recombinant lactoferrin (L...
Other Medicine News:Health News:Consumers and plastic surgeons say economy is cutting into cosmetic procedures 2Health News:DFine Secures $30 Million in Series D Funding 2Health News:Foundation Releases Comprehensive Regional Health Care Report Card 2Health News:Foundation Releases Comprehensive Regional Health Care Report Card 3Health News:Foundation Releases Comprehensive Regional Health Care Report Card 4Health News:A high-fat diet could promote the development of Alzheimer's 2Health News:NAMI Pennsylvania Announces Program for Annual Statewide Conference 2Health News:Global Scientific Research Collaboration Leads to Breakthrough in Culturing HEK 293 Cells in Animal-free Media 2
(Date:11/23/2009)...3/PRNewswire-FirstCall/-- LexiconPharmaceuticals,I...fromitsPhase2clinicalstudywith LX1031 inpatientswi...epresentedatGASTRO2009inLondonthisweek.Resultsfrom...mptoms,willbepresentedbyDr. PhilipM.Brown ,Lexicon...ber25,2009at2:30pmlocaltimeatthesessionentitled,"T...
(Date:11/23/2009)...RNewswire-FirstCall/--WoundManagementTechnologies,...rofspecialtymedicalproducts,announcedthatithasfile...ivemanagementbusinessupdatetoillustratethedevelopm...ncreased33.5%to$102,926vs.Q32008salesof$77,084. ,...27,892vs.Q32008shareholderequityof$(321,257) ,...
(Date:11/23/2009)...,Nov.23/PRNewswire-FirstCall/--Anesiva,Inc.(Nasdaq....U,PrichardhaveagreedtojointheAnesivaboardofdirect...esivaandArcionTherapeutics.Completionofthemergeris...previouslyannouncedAnesiva2009AnnualMeetingofStock...OysterPoint,Suite107A,SouthSanFrancisco,California...
Breaking Medicine Technology:Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men 57152 1Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men 57152 2Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men 57152 3Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 1Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 2Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 3Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 4Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 1Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 2Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 3Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 4